Enzene Biosciences launches Cetuximab, biosimilar of cancer drug Erbitux EP News Bureau May 29, 2023 Cetuximab is a therapeutic chimeric monoclonal antibody that is used as a targeted therapy for metastatic colorectal cancer (mCRC)…
